Clinical Research Directory
Browse clinical research sites, groups, and studies.
3 clinical studies listed.
Filters:
Tundra lists 3 Glycogen Storage Disease Type IA clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07875023
Effects of the Carbohydrate Counting Method on Blood Glucose Regulation, Quality of Life, Urinary Glc4 and Other Biomarkers in Children With GSD1
The goal of the study is to investigate the effects of carbohydrate counting training-administered to pediatric patients diagnosed with GSD 1a and 1b-on blood glucose regulation, quality of life, urinary glucotetrasaccharide (Glc4) levels, and various biomarkers. The main questions it aims to answer are: * Is there a significant change in the urinary Glc4 parameter of patients diagnosed with GSD1 who employ the carbohydrate counting method? * Does the implementation of the carbohydrate counting method in the diets of patients diagnosed with GSD1 lead to a significant change in their quality of life? * Is there a significant change in the HbA1c (%) levels of patients diagnosed with GSD1 who practice the carbohydrate counting method? * Does the application of the carbohydrate counting method in the diets of patients diagnosed with GSD1 result in a significant change in the frequency of infections? Children aged 2-18 years diagnosed with GSD1 will be monitored for a period of 3 months; during this time, food consumption records and anthropometric measurements will be collected, retrospective analysis of continuous glucose monitoring sensor(CGMS) data will be conducted, and various questionnaires and rating scales will be completed both online and in person.
Gender: All
Ages: 2 Years - 18 Years
Updated: 2026-10-15
NCT05139316
A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
The primary objectives of this study are to evaluate the efficacy of DTX401 to reduce or eliminate dependence on exogenous glucose replacement therapy to maintain euglycemia and to maintain or improve the quality of glucose control.
Gender: All
Ages: 8 Years - Any
Updated: 2026-10-14
14 states
NCT07459582
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.
Gender: All
Ages: Any - 60 Years
Updated: 2026-06-01
1 state